Medtronic (MDT:NYSE) Annual Reports & Investor Relations Material

Overview

Medtronic plc, a global leader in medical technology, develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. With a focus on improving patient outcomes, the company's Cardiovascular Portfolio segment offers a range of implantable cardiac devices, ablation products, monitoring systems, and patient-centered software. Additionally, their Medical Surgical Portfolio includes surgical stapling devices, electrosurgery products, and robotic-assisted surgery products, among other therapies. Medtronic's Neuroscience Portfolio offers products for a variety of specialists, including spinal surgeons, pain management specialists, and interventional radiologists. Finally, their Diabetes Operating Unit provides insulin pumps, continuous glucose monitoring systems, and smart insulin pen systems. Founded in 1949 and headquartered in Dublin, Ireland, Medtronic continues to drive innovation in the medical technology industry.

Frequently Asked Questions

What is Medtronic's ticker?

Medtronic's ticker is MDT

What exchange is Medtronic traded on?

The company's shares trade on the NYSE stock exchange

Where are Medtronic's headquarters?

They are based in Minneapolis, Minnesota

How many employees does Medtronic have?

There are 10,000+ employees working at Medtronic

What is Medtronic's website?

It is medtronic.com/us-en/index.html?intcmp=nasdaq_mdt_logo_home

What type of sector is Medtronic?

Medtronic is in the Healthcare sector

What type of industry is Medtronic?

Medtronic is in the Medical Appliances & Equipment industry

Who are Medtronic's peers and competitors?

The following five companies are Medtronic's industry peers:

- Escalon Medical Corp.

- Pressure BioSciences, Inc.

- STERIS

- GenMark Diagnostics, Inc.

- BrainsWay